Dancann Pharma As Stock Performance
| DCPXF Stock | 0.01 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and DanCann Pharma are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days DanCann Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, DanCann Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
DanCann |
DanCann Pharma Relative Risk vs. Return Landscape
If you would invest 1.00 in DanCann Pharma AS on August 30, 2024 and sell it today you would earn a total of 0.00 from holding DanCann Pharma AS or generate 0.0% return on investment over 90 days. DanCann Pharma AS is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than DanCann, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
DanCann Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for DanCann Pharma's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as DanCann Pharma AS, and traders can use it to determine the average amount a DanCann Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| DCPXF |
Based on monthly moving average DanCann Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DanCann Pharma by adding DanCann Pharma to a well-diversified portfolio.
Things to note about DanCann Pharma AS performance evaluation
Checking the ongoing alerts about DanCann Pharma for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for DanCann Pharma AS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| DanCann Pharma AS generated a negative expected return over the last 90 days | |
| DanCann Pharma AS has some characteristics of a very speculative penny stock |
- Analyzing DanCann Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DanCann Pharma's stock is overvalued or undervalued compared to its peers.
- Examining DanCann Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating DanCann Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of DanCann Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of DanCann Pharma's pink sheet. These opinions can provide insight into DanCann Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for DanCann Pink Sheet analysis
When running DanCann Pharma's price analysis, check to measure DanCann Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DanCann Pharma is operating at the current time. Most of DanCann Pharma's value examination focuses on studying past and present price action to predict the probability of DanCann Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DanCann Pharma's price. Additionally, you may evaluate how the addition of DanCann Pharma to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |